Compare Stocks → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:AMTOTCMKTS:EMED Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMTAmerican Tower$195.74+2.6%$184.67$154.58▼$219.10$91.41B0.712.46 million shs7.33 million shsEMEDElectromedical Technologies$0.00-33.3%$0.00$0.00▼$0.00N/AN/A4.58 million shs19.33 million shs5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMTAmerican Tower0.00%+5.28%+7.69%-5.05%+2.40%EMEDElectromedical Technologies0.00%-20.00%+60.00%+14.29%-38.46%[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMTAmerican Tower4.5307 of 5 stars3.53.01.73.12.82.51.3EMEDElectromedical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMTAmerican Tower2.91Moderate Buy$220.9112.86% UpsideEMEDElectromedical TechnologiesN/AN/AN/AN/ACurrent Analyst RatingsLatest EMED, 4DX, ADR, and AMT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/30/2024AMTAmerican TowerBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$234.00 ➝ $223.005/1/2024AMTAmerican TowerScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector Outperform ➝ Sector Outperform$243.00 ➝ $223.005/1/2024AMTAmerican TowerBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$228.00 ➝ $220.005/1/2024AMTAmerican TowerRaymond JamesSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeOutperform ➝ Strong-Buy$226.00 ➝ $248.004/15/2024AMTAmerican TowerMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$183.00 ➝ $196.004/8/2024AMTAmerican TowerMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$205.003/5/2024AMTAmerican TowerBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$224.00 ➝ $234.00(Data available from 6/3/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMTAmerican Tower$11.14B8.20$9.91 per share19.76$22.83 per share8.57EMEDElectromedical TechnologiesN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMTAmerican Tower$1.48B$4.4244.2919.021.4018.42%18.45%3.11%7/25/2024 (Estimated)EMEDElectromedical TechnologiesN/AN/A0.00∞N/AN/AN/AN/AN/ALatest EMED, 4DX, ADR, and AMT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2024Q1 2024AMTAmerican Tower$2.43$1.96-$0.47$1.96$2.79 billion$2.83 billion DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMTAmerican Tower$6.483.31%+12.50%146.61%N/AEMEDElectromedical TechnologiesN/AN/AN/AN/AN/ALatest EMED, 4DX, ADR, and AMT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/23/2024AMTAmerican Towerquarterly$1.623.47%6/14/20246/14/20247/12/20243/14/2024AMTAmerican Towerquarterly$1.623.3%4/11/20244/12/20244/26/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMTAmerican Tower3.390.850.85EMEDElectromedical TechnologiesN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMTAmerican Tower92.69%EMEDElectromedical Technologies0.01%Insider OwnershipCompanyInsider OwnershipAMTAmerican Tower0.18%EMEDElectromedical Technologies1.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAMTAmerican Tower5,643466.98 million466.13 millionOptionableEMEDElectromedical Technologies6N/AN/ANot OptionableEMED, 4DX, ADR, and AMT HeadlinesRecent News About These CompaniesMay 15, 2024 | valdostadailytimes.comeMed Partners with i3screen to Launch Virtual Drug Screening Program for EmployersMarch 28, 2024 | msn.comMTD acquires Ypsomed's pen needle and BGM businesses, strengthening its leading position in diabetes careOctober 26, 2023 | thestreet.comElectromedical Technologies IncMarch 22, 2023 | finance.yahoo.comElectromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement.March 14, 2023 | msn.comElectromedical Technologies expects Q4 revenue to be up 79% Y/YJanuary 2, 2023 | finance.yahoo.comElectromedical Technologies, Inc. (EMED)December 5, 2022 | finance.yahoo.comElectromedical Technologies Announces Financial and Operational Highlights for the Three and Nine Months Ended September 30, 2022November 1, 2022 | finance.yahoo.comElectromedical Technologies Introduces the WellnessPro Infinity™September 20, 2022 | seekingalpha.comEMED Electromedical Technologies, Inc.September 8, 2022 | finance.yahoo.comElectromedical's Flagship WellnessPro Plus Technology on Exhibit This Week at PAINWeek 2022 in Las Vegas from Sep 6-9August 18, 2022 | finance.yahoo.comElectromedical Technologies Announces Financial and Operational Highlights for the Three and Six Months Ended June 30, 2022May 24, 2022 | finance.yahoo.comElectromedical Technologies Announces Financial and Operational Highlights for the Three Months Ended March 31, 2022April 7, 2022 | finance.yahoo.comElectromedical Technologies Announces 2021 Annual Financial ResultsJanuary 17, 2022 | nasdaq.comElectromedical Technologies Inc (EMED)November 18, 2021 | finance.yahoo.comElectromedical Technologies, Inc. Reports Third Quarter 2021 Financial ResultsSeptember 30, 2021 | finance.yahoo.comElectromedical Technologies Receives Key Medical Device CertificationAugust 19, 2021 | finance.yahoo.comElectromedical Technologies Clarifies Comparative Six-Month Highlights Reported in August 18, 2021 Press ReleaseNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAmerican TowerNYSE:AMTAmerican Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.Electromedical TechnologiesOTCMKTS:EMEDElectromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. It offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. The company also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
